🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 11 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/10/2024 54,50 54,85 53,15 53,81 -2,11% 3,12% 946.700
18/10/2024 54,45 55,15 54,07 54,97 +0,81% 1,98% 1.416.400
17/10/2024 55,29 55,34 54,19 54,53 -1,36% 2,08% 931.400
16/10/2024 56,10 56,10 54,59 55,28 -0,18% 2,69% 807.700
15/10/2024 54,54 56,02 53,88 55,38 +1,61% 3,92% 796.600
14/10/2024 54,59 54,70 53,80 54,50 -0,69% 1,65% 1.246.200
11/10/2024 52,97 55,26 52,62 54,88 +3,25% 4,98% 1.151.500
10/10/2024 53,52 54,13 52,96 53,15 -2,30% 2,19% 942.100
09/10/2024 55,42 56,30 54,22 54,40 +0,13% 3,75% 852.000
08/10/2024 55,29 55,88 54,30 54,33 -2,06% 2,86% 809.400
07/10/2024 56,39 56,99 55,36 55,47 -2,13% 2,89% 931.000
04/10/2024 55,75 56,90 55,68 56,68 +1,74% 2,19% 1.189.800
03/10/2024 52,53 55,81 52,08 55,71 +5,89% 7,10% 1.513.100
02/10/2024 51,60 54,16 51,60 52,61 +0,02% 4,96% 900.100
01/10/2024 52,44 52,78 51,63 52,60 -0,38% 2,19% 990.800
30/09/2024 52,10 52,96 51,66 52,80 +0,88% 2,50% 1.057.200
27/09/2024 53,17 53,42 52,01 52,34 -0,55% 2,65% 861.000
26/09/2024 53,50 53,50 52,10 52,63 -0,09% 2,62% 859.200
25/09/2024 52,81 53,94 52,40 52,68 +0,04% 2,92% 1.054.600
24/09/2024 51,92 52,89 51,47 52,66 +1,09% 2,73% 1.467.000
23/09/2024 53,95 54,54 52,08 52,09 -3,12% 4,56% 1.358.000
20/09/2024 55,45 55,88 53,60 53,77 -3,29% 4,11% 3.186.400
19/09/2024 54,99 56,27 53,26 55,60 -0,61% 5,47% 2.725.400
18/09/2024 56,95 57,76 53,88 55,94 -0,39% 6,81% 1.376.600
17/09/2024 57,00 57,48 53,31 56,16 -1,04% 7,32% 2.143.500
16/09/2024 56,46 57,03 55,44 56,75 +1,56% 2,82% 809.400
13/09/2024 54,34 56,20 54,08 55,88 +3,37% 3,90% 879.800
12/09/2024 53,78 55,41 53,51 54,06 +0,54% 3,53% 894.400
11/09/2024 53,69 54,06 52,85 53,77 -0,70% 2,25% 726.900
10/09/2024 56,03 56,19 53,80 54,15 -3,01% 4,27% 788.500